Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
2022-12-03 09:58
China Pharma Announces Receipt of Noncompliance Notice from NYSE American
2022-12-03 05:10
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus
2022-12-03 05:05
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022
2022-12-02 16:20
Waterdrop Inc. to Report Third Quarter 2022 Financial Results on December 6, 2022
2022-12-02 11:43
Jacobio's Preclinical Results of KRAS G12C Inhibitor in Combination with SHP2 Inhibitor Will be Presented at the ESMO Asia Congress 2022
2022-12-02 08:30
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met
2022-12-01 19:30
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results
2022-12-01 15:33
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO
2022-12-01 09:30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-12-01 08:00
TIANGEN to Roll out a Stunning Automated Solution at Cell Bio 2022
2022-11-30 21:20
Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne
2022-11-30 20:39
Navigating a perfect storm - driving access to healthcare in emerging markets
2022-11-30 15:00
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan
2022-11-30 08:00
COSMAX Group Expands Business to Pet Care...Targeting $200B Market
2022-11-29 22:00
United Imaging Selected to Academy of Radiology & Biomedical Imaging Research's Council of Distinguished Investigators' Class of 2022
2022-11-29 22:00
Mintal Tracker Wins Highest Honor From Prestigious 2022 Fall Digital Health Awards
2022-11-29 21:00
Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment
2022-11-29 16:20
AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
2022-11-29 13:24
Cambridge Cognition and Luca Healthcare Announce a Strategic Partnership and an Exclusive Licensing Agreement to Commercialize Cambridge Cognition's Suite of Cognitive Assessment Tools and Brain Health Products for the China Market
2022-11-29 10:00
1
125
126
127
128
129
812